Enlitisa (shanghai) Pharmaceutical Co., Ltd

Jiangyin Usun Pharmaceutical Co., Ltd.

Jiangsu Amer New Material Co., Ltd.

Ming Gu

Bengt Ingemar Samuelsson

Junjie Zhao

Wanyu Pan

Provided a peptide of the sequence Ala-Lys-Pro-Ser-Tyr-Hyp-Hyp-Thr-DOPA-Lys or a salt thereof for use in the treatment of inflammation, of an inflammatory disorder and/or of ion thea condition characterized by inflammation, including wounds, burns, psoriasis, acne and atopic dermatitis.

Anti-inflammatory use of peptide

An integrated system for automatic forming, picking, and inspection of a grinding wheel mesh piece and a method thereof, including a visual inspection system (), a conveying system (), a cutting system (), and a picking system (); the conveying system () is used to precisely control a conveying action of a cutting section conveying platform () and a picking section conveying platform (), and the visual inspection system () is used to acquire an image of a grinding wheel mesh cloth, establish virtual origin coordinates of a cutting layout and center coordinates of the grinding wheel mesh piece after cutting, recognize defects of the grinding wheel mesh cloth, and calibrate qualified center coordinates and unqualified center coordinates; the cutting system () is used to cut the grinding wheel mesh cloth moved to the cutting section conveying platform () to obtain a circular grinding wheel mesh piece.

Integrated system for automatic forming, picking, and inspection of grinding wheel mesh piece and method therefor

There is provided a peptide-containing compound that comprises a peptide component which is an amino acid sequence of from 2 to 45 (e.g. from 6 to 15) amino acids, which peptide component is covalently bonded to one or more compounds of formula I: wherein:

Conjugates of montelukast and peptides

There is provided topical pharmaceutical formulations comprising montelukast, or a pharmaceutical acceptable salt of solvate thereof, as well as combination products comprising (a) at least one mussel adhesive protein or a derivative thereof; and (b) montelukast, or a pharmaceutically-acceptable salt or solvate thereof. The formulations and combination products find particular utility in direct topical administration for the treatment of inflammation, of inflammatory disorders and/or of condition characterized by inflammation, including wounds, burns, psoriasis, acne and atopic dermatitis.

Growing community of inventors

Jiangsu, China

Ming Gu